We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Aids for Spinal Surgery

By HospiMedica staff writers
Posted on 17 Oct 2005
New aids and devices specially designed for minimally disruptive surgical treatments for the spine have been announced by NuVasive, Inc. More...
(San Diego, CA, USA).

MaXcess II, an enhancement of the MaXcess system, features three blades that slide down over NuVasive's NeuroVision dilators and gently spread apart the patient's tissue. The superior and inferior blades "kick-out” at an angle, spreading the tissue closest to the pathology point. MaXcess II also allows for greater exposure and access to the spine while requiring no greater incision, and offers a retraction system that is radiolucent or translucent to x-rays, giving the surgeon a full view of the pathology point during fluoroscopy.

CoRoent large contoured implant and CoRoent XLR systems are designed to allow for simplicity of surgeon placement and proper anatomical fit in the spine. Both are radiolucent and include radio-dense titanium markers, enabling the surgeon to visually confirm their correct positioning. These products are made of Peek Optima, a biocompatible polymer commonly used in implantable devices.

NuVasive has also made enhancements to its NeuroVision nerve-avoidance system in the form of a software upgrade and improved nerve-monitoring capabilities. NeuroVision has also been given a new harness and dual electrodes to streamline the application of surface electrodes that relay muscle activity to the nerve-monitoring system.

"We are particularly excited about the launch of MaXcess II, which we believe provides surgeons with the greatest access to the spine in a minimally disruptive procedure available on the market,” said Alexis V. Lukianov, chairman and CEO of NuVasive.




Related Links:
NuVasive

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.